Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
920
-
Total shares
-
73.5M
-
Shares change
-
+1.58M
-
Total reported value, excl. options
-
$25.8B
-
Value change
-
+$443M
-
Put/Call ratio
-
0.7
-
Number of buys
-
398
-
Number of sells
-
-512
-
Price
-
$350.73
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2022
943 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2022.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 920 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.5M shares
of 80.8M outstanding shares and own 90.98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.43M shares), VANGUARD GROUP INC (8.06M shares), STATE STREET CORP (3.65M shares), Fundsmith LLP (3.62M shares), ALLIANCEBERNSTEIN L.P. (2.78M shares), BAMCO INC /NY/ (2.42M shares), FMR LLC (2.07M shares), GEODE CAPITAL MANAGEMENT, LLC (1.86M shares), AMERICAN CENTURY COMPANIES INC (1.53M shares), and BLAIR WILLIAM & CO/IL (1.23M shares).
This table shows the top 920 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.